The Role of AI in Scientific Discovery
NBC San Francisco's Press:Here program featured Dotmatics CEO Thomas Swalla discussing how artificial intelligence can enhance scientists' capabilities and accelerate scientific discovery.
NBC San Francisco's Press:Here program explores trends in technology with world experts. Thomas Swalla, the CEO of Dotmatics, was featured as a guest to explore what artificial intelligence could do to augment the power scientists bring to research and aid in scientific discovery.
Related
Scripps News America Tonight
Phil Mounteney, VP of Science and Technology at Dotmatics, explains in Scripps News America Tonight how Dotmatics Luma uses AI to transform scientific research and pharmaceutical drug discovery by accelerating innovation, lowering costs, and shortening time-to-market for modern laboratories.
Dotmatics helping scientists make better drugs in less time using AI
Dotmatics executives Kalim Saliba and Steve Tharp explain in a CBS News Boston feature how the company leverages artificial intelligence to transform pharmaceutical drug discovery by providing innovative solutions that accelerate and improve the efficiency of scientific research and development in the life sciences sector.
The Future of AI in Drug Discovery
The Forbes article discusses how AI is revolutionizing drug discovery by accelerating R&D and improving decision-making, highlighting Dotmatics’ role in integrating data and applying AI to scientific workflows, while also connecting these advancements to broader innovations in sustainability and global problem-solving.
NBC News: How AI is Transforming Drug Discovery
In an NBC News segment, Alister Campbell, VP of Dotmatics, explains how the company leverages AI to analyze large datasets, predict effective drug compounds, and streamline fragmented data systems and manual workflows, thereby accelerating and improving the efficiency of drug discovery.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
Gray TV Washington DC: AI helping scientists make drug breakthroughs
The Gray TV Washington DC feature highlights how scientists, including Christian Olsen of Dotmatics, are leveraging AI and machine learning to accelerate drug discovery and expedite bringing new drugs to market.